Table 1.
Clinicopathological parameters of breast cancer (BC) patients studied.
| Parameters | BC Patients |
|---|---|
| Sample size (n) | 31 |
| Age (mean ± SD) | 58.8 ± 15.5 |
| Range in years | 30–90 |
| Tumor Size (mm) | |
| ≤ 20 | 19 |
| > 20 | 9 |
| Tumor Grade | |
| I | 4 |
| II | 11 |
| III | 13 |
| Lymph Node Metastasis | |
| Positive | 4 |
| Negative | 24 |
| Estrogen Receptor | |
| Positive | 16 |
| Negative | 15 |
| Progesterone Receptor | |
| Positive | 16 |
| Negative | 15 |
| HER2 Overexpression | |
| Positive | 0 |
| Negative | 31 |
| Proliferation Index (Ki-67) | |
| ≤ 14% | 16 |
| > 14% | 13 |
HER2: human epidermal growth factor receptor 2.